BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guglielmi A, Ruzzenente A, Campagnaro T, Pachera S, Valdegamberi A, Capelli P, Pedica F, Nicoli P, Conci S, Iacono C. Does intrahepatic cholangiocarcinoma have better prognosis compared to perihilar cholangiocarcinoma? J Surg Oncol 2010;101:111-5. [PMID: 19953578 DOI: 10.1002/jso.21452] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Liu WW, Tu JF, Ying XH, Chen ZJ, Wang YB. Postoperative survival of extrahepatic and intrahepatic cholangiocarcinoma after surgery: a population-based cohort. BMJ Open 2022;12:e049789. [PMID: 35414539 DOI: 10.1136/bmjopen-2021-049789] [Reference Citation Analysis]
2 Tao J, Jiang L, Chen X. Roles of microRNA in liver cancer. Liver Research 2018;2:61-72. [DOI: 10.1016/j.livres.2018.06.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
3 Ercolani G, Dazzi A, Giovinazzo F, Ruzzenente A, Bassi C, Guglielmi A, Scarpa A, D'errico A, Pinna A. Intrahepatic, peri-hilar and distal cholangiocarcinoma: Three different locations of the same tumor or three different tumors? European Journal of Surgical Oncology (EJSO) 2015;41:1162-9. [DOI: 10.1016/j.ejso.2015.05.013] [Cited by in Crossref: 46] [Cited by in F6Publishing: 52] [Article Influence: 6.6] [Reference Citation Analysis]
4 Yang LC, Shi HY, Huang JW, Lee KT. Biliary stenting for unresectable cholangiocarcinoma: A population-based study of long-term outcomes and hospital costs in Taiwan. Kaohsiung J Med Sci 2015;31:370-6. [PMID: 26162818 DOI: 10.1016/j.kjms.2015.05.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
5 Simbolo M, Fassan M, Ruzzenente A, Mafficini A, Wood LD, Corbo V, Melisi D, Malleo G, Vicentini C, Malpeli G, Antonello D, Sperandio N, Capelli P, Tomezzoli A, Iacono C, Lawlor RT, Bassi C, Hruban RH, Guglielmi A, Tortora G, de Braud F, Scarpa A. Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups. Oncotarget 2014;5:2839-52. [PMID: 24867389 DOI: 10.18632/oncotarget.1943] [Cited by in Crossref: 121] [Cited by in F6Publishing: 181] [Article Influence: 17.3] [Reference Citation Analysis]
6 Azodo IA, Parks RW, Garden OJ. Epidemiology of Cholangiocarcinoma and Gallbladder Carcinoma. Biliary Tract and Gallbladder Cancer 2014. [DOI: 10.1007/978-3-642-40558-7_1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
7 Guglielmi A, Ruzzenente A, Valdegamberi A, Bagante F, Conci S, Pinna AD, Ercolani G, Giuliante F, Capussotti L, Aldrighetti L. Hepatolithiasis-associated cholangiocarcinoma: results from a multi-institutional national database on a case series of 23 patients. Eur J Surg Oncol. 2014;40:567-575. [PMID: 24388409 DOI: 10.1016/j.ejso.2013.12.006] [Cited by in Crossref: 19] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
8 Ruzzenente A, Iacono C, Conci S, Bertuzzo F, Salvagno G, Ruzzenente O, Campagnaro T, Valdegamberi A, Pachera S, Bagante F, Guglielmi A. A novel serum marker for biliary tract cancer: diagnostic and prognostic values of quantitative evaluation of serum mucin 5AC (MUC5AC). Surgery 2014;155:633-9. [PMID: 24468034 DOI: 10.1016/j.surg.2013.12.003] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
9 Yang H, Li TW, Peng J, Tang X, Ko KS, Xia M, Aller MA. A mouse model of cholestasis-associated cholangiocarcinoma and transcription factors involved in progression. Gastroenterology 2011;141:378-88, 388.e1-4. [PMID: 21440549 DOI: 10.1053/j.gastro.2011.03.044] [Cited by in Crossref: 87] [Cited by in F6Publishing: 94] [Article Influence: 7.9] [Reference Citation Analysis]
10 Guglielmi A, Ruzzenente A, Campagnaro T, Pachera S, Conci S, Valdegamberi A, Sandri M, Iacono C. Prognostic significance of lymph node ratio after resection of peri-hilar cholangiocarcinoma. HPB (Oxford) 2011;13:240-5. [PMID: 21418129 DOI: 10.1111/j.1477-2574.2010.00277.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 3.8] [Reference Citation Analysis]
11 Murakami Y, Uemura K, Sudo T, Hashimoto Y, Nakashima A, Kondo N, Sakabe R, Ohge H, Sueda T. Prognostic factors after surgical resection for intrahepatic, hilar, and distal cholangiocarcinoma. Ann Surg Oncol 2011;18:651-8. [PMID: 20945107 DOI: 10.1245/s10434-010-1325-4] [Cited by in Crossref: 161] [Cited by in F6Publishing: 173] [Article Influence: 13.4] [Reference Citation Analysis]